ABVC Biopharma Income Tax Expense Over Time

ABVC Stock  USD 0.47  0.01  1.06%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ABVC Biopharma Performance and ABVC Biopharma Correlation.
For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.
  
The current year's Income Tax Expense is expected to grow to about 268.8 K.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ABVC Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.81)
Revenue Per Share
0.017
Quarterly Revenue Growth
18.175
Return On Assets
(0.45)
Return On Equity
(3.20)
The market value of ABVC Biopharma is measured differently than its book value, which is the value of ABVC that is recorded on the company's balance sheet. Investors also form their own opinion of ABVC Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ABVC Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ABVC Biopharma's market value can be influenced by many factors that don't directly affect ABVC Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ABVC Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABVC Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABVC Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Income Tax Expense Analysis

Compare ABVC Biopharma and related stocks such as Equillium, DiaMedica Therapeutics, and Valneva SE ADR Income Tax Expense Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
EQ0.00.00.00.00.00.00.00.0140.5 K(23 K)(45 K)(72 K)45.3 M580 K551 K
DMAC69.9 K12.6 K2.7 K7.7 K42.3 K12.4 K22.3 K(9 K)80 K31 K27 K28 K28 K43 K45.2 K
VALN(176 K)26 K96 K348 K334 K224 K356 K1.1 M88 K874 K(909 K)3.4 M(1.5 M)2.8 M2.9 M
VANI9.3 K9.3 K9.3 K42.2 K(6.9 M)58 K31 K93 K86 K362 K147.7 K(641 K)(7.4 M)(6.6 M)(6.3 M)
DNLI0.00.00.00.00.00.00.0(3.1 M)10.1 M(351 K)823 K(575 K)21 K30 K28.5 K
DNTH236 K236 K236 K236 K236 K236 K236 K236 K2.4 M6.2 M7.5 M(2 M)(1.3 M)187.1 K177.8 K
DOMH100 K14.5 K385 K2.6 M(48 K)40.3 M456 K(225 K)(6.5 M)(1.5 M)5.6 M(252 K)16.5 M300 K285 K
VCEL(1.3 M)(18.7 M)(4.2 M)(5.3 M)(3.6 M)(257 K)2.6 M1.1 M3.4 M(1.8 M)180 K(111 K)721 K814 K854.7 K
VCNXMMMMMMM1.3 M(1.8 M)152 K458 K852 K(93 K)(48.9 K)(46.5 K)
VCYT819 K819 K(2 K)(2.9 M)(664 K)518 KM5.4 M1.2 M3.9 M938 K(6.1 M)133 K(2.2 M)(2.1 M)

ABVC Biopharma and related stocks such as Equillium, DiaMedica Therapeutics, and Valneva SE ADR Income Tax Expense description

My Equities

My Current Equities and Potential Positions

ABVC Biopharma
ABVC
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationCalifornia; U.S.A
ExchangeNASDAQ Exchange
USD 0.475
When determining whether ABVC Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ABVC Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Abvc Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Abvc Biopharma Stock:
Check out ABVC Biopharma Performance and ABVC Biopharma Correlation.
For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
ABVC Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ABVC Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ABVC Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...